Patents by Inventor Jason E. Fernandez

Jason E. Fernandez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING MOLECULES
    Publication number: 20220175923
    Abstract: The invention relates to formulations of single domain antigen binding molecules, e.g., nanobody molecules, in particular formulations of TNF-binding nanobody molecules. The single domain antigen binding molecules can include one or more single binding domains that interact with, e.g., bind to, one or more target proteins. The formulations are useful, e.g., as pharmaceutical formulations. Method of preparing, and using the formulations described herein, to treat, e.g., TNF-associated disorders, are also disclosed.
    Type: Application
    Filed: November 22, 2021
    Publication date: June 9, 2022
    Applicant: Ablynx N.V.
    Inventors: Jason E. Fernandez, Daniel A. Dixon, Andrea Paulson
  • FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING MOLECULES
    Publication number: 20180353604
    Abstract: The invention relates to formulations of single domain antigen binding molecules, e.g., nanobody molecules, in particular formulations of TNF-binding nanobody molecules. The single domain antigen binding molecules can include one or more single binding domains that interact with, e.g., bind to, one or more target proteins. The formulations are useful, e.g., as pharmaceutical formulations. Method of preparing, and using the formulations described herein, to treat, e.g., TNF-associated disorders, are also disclosed.
    Type: Application
    Filed: May 3, 2018
    Publication date: December 13, 2018
    Applicant: Ablynx N.V.
    Inventors: JASON E. FERNANDEZ, Daniel A. Dixon, Andrea Paulson
  • Formulations of single domain antigen binding molecules
    Patent number: 9993552
    Abstract: The invention relates to formulations of single domain antigen binding molecules, e.g., nanobody molecules, in particular formulations of TNF-binding nanobody molecules. The single domain antigen binding molecules can include one or more single binding domains that interact with, e.g., bind to, one or more target proteins. The formulations are useful, e.g., as pharmaceutical formulations. Method of preparing, and using the formulations described herein, to treat, e.g., TNF-associated disorders, are also disclosed.
    Type: Grant
    Filed: February 11, 2016
    Date of Patent: June 12, 2018
    Assignee: Ablynx N.V.
    Inventors: Jason E. Fernandez, Daniel A. Dixon, Andrea Paulson
  • FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING MOLECULES
    Publication number: 20160263220
    Abstract: The invention relates to formulations of single domain antigen binding molecules, e.g., nanobody molecules, in particular formulations of TNF-binding nanobody molecules. The single domain antigen binding molecules can include one or more single binding domains that interact with, e.g., bind to, one or more target proteins. The formulations are useful, e.g., as pharmaceutical formulations. Method of preparing, and using the formulations described herein, to treat, e.g., TNF-associated disorders, are also disclosed.
    Type: Application
    Filed: February 11, 2016
    Publication date: September 15, 2016
    Applicant: Ablynx N.V.
    Inventors: JASON E. FERNANDEZ, Daniel A. Dixon, Andrea Paulson
  • Formulations of single domain antigen binding molecules
    Patent number: 9393304
    Abstract: The invention relates to formulations of single domain antigen binding molecules, e.g., nanobody molecules, in particular formulations of TNF-binding nanobody molecules. The single domain antigen binding molecules can include one or more single binding domains that interact with, e.g., bind to, one or more target proteins. The formulations are useful, e.g., as pharmaceutical formulations. Method of preparing, and using the formulations described herein, to treat, e.g., TNF-associated disorders, are also disclosed.
    Type: Grant
    Filed: October 29, 2009
    Date of Patent: July 19, 2016
    Assignee: Ablynx N.V.
    Inventors: Jason E. Fernandez, Daniel A. Dixon, Andrea Paulson
  • FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING MOLECULES
    Publication number: 20100137213
    Abstract: The invention relates to formulations of single domain antigen binding molecules, e.g., nanobody molecules, in particular formulations of TNF-binding nanobody molecules. The single domain antigen binding molecules can include one or more single binding domains that interact with, e.g., bind to, one or more target proteins. The formulations are useful, e.g., as pharmaceutical formulations. Method of preparing, and using the formulations described herein, to treat, e.g., TNF-associated disorders, are also disclosed.
    Type: Application
    Filed: October 29, 2009
    Publication date: June 3, 2010
    Applicant: WYETH
    Inventors: Jason E. Fernandez, Daniel A. Dixon, Andrea Paulson